Dr. Sara Nasser
Clinical Lead
sara@www.embryomic.com
Dr. Sara Nasser brings extensive clinical and research expertise to Embryomic, drawing from her experience at two of Europe’s largest comprehensive cancer centres-Charité Comprehensive Cancer Center in Berlin and Policlinico Agostino Gemelli Cancer Center in Rome. As a trained Obstetrician and Gynecologist subspecializing in gynecological oncology, she has practiced across Italy, Germany, and the UK. With her clinical and research experience across Europe and her leadership in global health programs in low-resource settings, she combines frontline expertise with a commitment to transformative change in oncology and fertility care.
As a devoted advocate for women’s health and empowerment, Dr. Nasser serves as Vice President and Co-Founder of the Pan Arabian Research Society for Gynecologic Oncology (PARSGO e.V). She is also an active global stakeholder committee member of the United Nation Family Planning Association’s WomenX Collective. In these roles Dr. Nasser has deeply impacted patient advocacy and healthcare equity within the Arab-speaking and African diaspora a mission that aligns closely with Embryomic’s ethos of improving outcomes for families worldwide.
In her role as Clinical Research Lead, Dr. Nasser ensures the clinical translational integrity of Embryomic’s test pipeline. Her leadership bridges elite science with patient-centred care, paving the way for Embryomic to deliver its metabolomic insights into IVF with compassion, rigor, and global vision.
Embryomic